1. Table of Contents
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Gastrointestinal Stromal Tumor (GIST) Ongoing Clinical Trials Overview, 2019
2.2 Premium Insights into Ongoing Clinical Trials
2.2.1 Ongoing Gastrointestinal Stromal Tumor (GIST) Clinical Trials by Region
2.2.2 Average Enrollment of Gastrointestinal Stromal Tumor (GIST) Clinical Trials
2.2.3 Companies participating in Ongoing Trials
2.2.4 Drugs under Study for Gastrointestinal Stromal Tumor (GIST) Treatment, 2019

3. Region wise Gastrointestinal Stromal Tumor (GIST) Clinical Trials
3.1 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Clinical Trials by Country
3.2 Europe Gastrointestinal Stromal Tumor (GIST) Clinical Trials by Country
3.3 North America Gastrointestinal Stromal Tumor (GIST) Clinical Trials by Country
3.4 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Clinical Trials by Country
3.5 South and Central America Gastrointestinal Stromal Tumor (GIST) Clinical Trials by Country

4. Gastrointestinal Stromal Tumor (GIST) Clinical Trial Trends
4.1 Start Year wise Ongoing Gastrointestinal Stromal Tumor (GIST) Clinical Trials
4.2 Phase wise Ongoing Gastrointestinal Stromal Tumor (GIST) Clinical Trials
4.3 Trial Status wise Ongoing Gastrointestinal Stromal Tumor (GIST) Clinical Trials
4.4 Trial Type wise Ongoing Gastrointestinal Stromal Tumor (GIST) Clinical Trials

5. Gastrointestinal Stromal Tumor (GIST) Average Enrollment Trends
5.1 Average Enrollment in Gastrointestinal Stromal Tumor (GIST) Trials by Year
5.2 Average Enrollment in Gastrointestinal Stromal Tumor (GIST) Trials by Phase
5.3 Average Enrollment in Gastrointestinal Stromal Tumor (GIST) Trials by Status
5.4 Average Enrollment in Gastrointestinal Stromal Tumor (GIST) Trials by Type of Trial

6. Companies Participating in Ongoing Gastrointestinal Stromal Tumor (GIST) Clinical Trials
6.1 Ongoing Gastrointestinal Stromal Tumor (GIST) Trials by Sponsor Type
6.2 Gastrointestinal Stromal Tumor (GIST) Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Ongoing Gastrointestinal Stromal Tumor (GIST) Trials- Phase 1
7.2 Ongoing Gastrointestinal Stromal Tumor (GIST) Trials- Phase 2
7.3 Ongoing Gastrointestinal Stromal Tumor (GIST) Trials- Phase 3
7.4 Ongoing Gastrointestinal Stromal Tumor (GIST) Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Gastrointestinal Stromal Tumor (GIST) Ongoing Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Ongoing Gastrointestinal Stromal Tumor (GIST) Clinical Trials and Enrolment
Figure 5: Europe – Country wise Ongoing Gastrointestinal Stromal Tumor (GIST) Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Ongoing Gastrointestinal Stromal Tumor (GIST) Clinical Trials and Enrolment
Figure 7: North America – Country wise Ongoing Gastrointestinal Stromal Tumor (GIST) Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Ongoing Gastrointestinal Stromal Tumor (GIST) Clinical Trials and Enrolment
Figure 9: Gastrointestinal Stromal Tumor (GIST) Ongoing Clinical Trials by Phase
Figure 10: Gastrointestinal Stromal Tumor (GIST) Ongoing Clinical Trials by Trial Status
Figure 11: Gastrointestinal Stromal Tumor (GIST) Ongoing Clinical Trials by Type
Figure 12: Gastrointestinal Stromal Tumor (GIST) Ongoing Clinical Trials by Sponsor Type
Figure 13: Gastrointestinal Stromal Tumor (GIST) Ongoing Clinical Trials by Leading Sponsors
Figure 14: Gastrointestinal Stromal Tumor (GIST) Average Enrollment by Phase
Figure 15: Gastrointestinal Stromal Tumor (GIST) Average Enrollment by Trial Status
Figure 16: Gastrointestinal Stromal Tumor (GIST) Average Enrollment by Type
Figure 17: Gastrointestinal Stromal Tumor (GIST)- Average Enrolment by Type of Sponsors
Figure 18: Gastrointestinal Stromal Tumor (GIST)- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List of Tables
Table 1: Gastrointestinal Stromal Tumor (GIST) Ongoing Clinical Trials Snapshot- 2019
Table 2: Ongoing Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Ongoing Gastrointestinal Stromal Tumor (GIST) Clinical Trials and Enrolment
Table 5: Europe – Country wise Ongoing Gastrointestinal Stromal Tumor (GIST) Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Ongoing Gastrointestinal Stromal Tumor (GIST) Clinical Trials and Enrolment
Table 7: North America – Country wise Ongoing Gastrointestinal Stromal Tumor (GIST) Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Ongoing Gastrointestinal Stromal Tumor (GIST) Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Gastrointestinal Stromal Tumor (GIST) Average Enrollment by Phase
Table 15: Gastrointestinal Stromal Tumor (GIST) Average Enrollment by Trial Status
Table 16: Gastrointestinal Stromal Tumor (GIST) Average Enrollment by Type
Table 17: Gastrointestinal Stromal Tumor (GIST)- Average Enrolment by Type of Sponsors
Table 18: Gastrointestinal Stromal Tumor (GIST)- Enrolment by Leading Sponsors